Scalable transactions in the cloud: partitioning revisited

Lecture Notes in Computer Science, 6427Cloud computing is becoming one of the most used paradigms to deploy highly available and scalable systems. These systems usually demand the management of huge amounts of data, which cannot be solved with traditional nor replicated database systems as we know them. Recent solutions store data in special key-value structures, in an approach that commonly lacks the consistency provided by transactional guarantees, as it is traded for high scalability and availability. In order to ensure consistent access to the information, the use of transactions is required. However, it is well-known that traditional replication protocols do not scale well for a cloud environment. Here we take a look at current proposals to deploy transactional systems in the cloud and we propose a new system aiming at being a step forward in achieving this goal. We proceed to focus on data partitioning and describe the key role it plays in achieving high scalability.This work has been partially supported by the Spanish Government under grant TIN2009-14460-C03-02 and by the Spanish MEC under grant BES-2007-17362 and by project ReD Resilient Database Clusters (PDTC/EIA-EIA/109044/2008)

Validating the concept of mutational signatures with isogenic cell models.

The diversity of somatic mutations in human cancers can be decomposed into individual mutational signatures, patterns of mutagenesis that arise because of DNA damage and DNA repair processes that have occurred in cells as they evolved towards malignancy. Correlations between mutational signatures and environmental exposures, enzymatic activities and genetic defects have been described, but human cancers are not ideal experimental systems-the exposures to different mutational processes in a patient's lifetime are uncontrolled and any relationships observed can only be described as an association. Here, we demonstrate the proof-of-principle that it is possible to recreate cancer mutational signatures in vitro using CRISPR-Cas9-based gene-editing experiments in an isogenic human-cell system. We provide experimental and algorithmic methods to discover mutational signatures generated under highly experimentally-controlled conditions. Our in vitro findings strikingly recapitulate in vivo observations of cancer data, fundamentally validating the concept of (particularly) endogenously-arising mutational signatures